Qingyong Li

5PUBLICATIONS
6CO-AUTHORS
PharmacogenomicsMolecular targetsCheminformatics and quantitative structure-activity relationshipsCancer therapy (excl. chemotherapy and radiation therapy)Liquid biopsies
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Sep 10, 2026
AI-Guided Discovery of Natural-Product-Inspired Scaffolds as Dual P-gp/BCRP Inhibitors to Overcome Cancer Multidrug Resistance.

|Jul 27, 2026
Molecular Construction and Anti-Bladder Cancer Study of Novel TOP1/PARP1 Dual-Target Inhibitors.

|Jan 02, 2026
Design and Synthesis of Novel Dual Fluoro-Substituted 10,11-Methylenedioxy-pyrrolo[3,4-b]quinoline Alkaloid Analogs as Topo I/DDX5 Inhibitors for Colorectal Cancer.

Wenchao Wang, Lei Li, Junrong Lei

|Dec 15, 2023
Structure-Activity Relationship of FL118 Platform Position 7 Versus Position 9-Derived Compounds and Their Mechanism of Action and Antitumor Activity.

Wenchao Wang, Xiang Ling, Ruojiong Wang

|Apr 29, 2019
In vitro evaluation of FL118 and 9-Q20 cytotoxicity and cellular uptake in 2D and 3D different cell models.

Qi Weng, Leilei Zhou, Lihua Xia

Pageof 1

Frequent Collaborators

4 joint publications

Wenchao Wang

4 joint publications

Hong Wang

1 joint publications

Hua Chen

1 joint publications

Xiaoze Bao